RPHCF(RPHCF)
RPHCF
No analyst ratings available
No analyst price targets available for RPHCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $373.36B | $391.37B | $409.34B | $425.23B | $456.76B |
| Low | $357.57B | $372.48B | $390.78B | $405.94B | $436.04B |
| High | $377.39B | $404.34B | $418.43B | $434.67B | $466.90B |
| EBITDA Avg | $66.81B | $70.03B | $73.24B | $76.09B | $81.73B |
| Low | $63.98B | $66.65B | $69.92B | $72.64B | $78.02B |
| High | $67.53B | $72.35B | $74.87B | $77.78B | $83.54B |
| EBIT Avg | $52.14B | $54.66B | $57.16B | $59.38B | $63.79B |
| Low | $49.93B | $52.02B | $54.57B | $56.69B | $60.89B |
| High | $52.70B | $56.47B | $58.43B | $60.70B | $65.20B |
| Net Income Avg | $37.24B | $39.50B | $41.55B | $44.53B | $47.17B |
| Low | $35.04B | $37.17B | $39.10B | $41.90B | $44.39B |
| High | $38.31B | $40.64B | $42.75B | $45.81B | $48.53B |
| EPS Avg | $158.15 | $167.74 | $176.45 | $189.11 | $200.33 |
| Low | $148.83 | $157.85 | $166.05 | $177.97 | $188.52 |
| High | $162.72 | $172.58 | $181.55 | $194.58 | $206.11 |
| Analysts (Rev / EPS) | 9 / 1 | 10 / 1 | 5 / 1 | 5 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $89.67B | $97.47B | $97.39B |
| Low | $89.44B | $96.64B | $96.84B |
| High | $89.95B | $98.46B | $98.06B |
| EBITDA Avg | $16.04B | $17.44B | $17.43B |
| Low | $16.00B | $17.29B | $17.33B |
| High | $16.10B | $17.62B | $17.55B |
| EBIT Avg | $12.52B | $13.61B | $13.60B |
| Low | $12.49B | $13.50B | $13.52B |
| High | $12.56B | $13.75B | $13.69B |
| Net Income Avg | $7.16B | $11.72B | $8.48B |
| Low | $7.11B | $11.63B | $8.42B |
| High | $7.22B | $11.82B | $8.56B |
| EPS Avg | $31.26 | $51.16 | $37.04 |
| Low | $31.03 | $50.78 | $36.77 |
| High | $31.54 | $51.61 | $37.37 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 |